Research area · week to 3 Oct 2026

Gastric Cancer Management and Outcomes

Moving in Gut, Gastroenterology, Cancer Cell.

Moved this week: 0

Rebuilt 3 October 2026 at 3:19 pm AEST

Moved this week

Everything that moved →

Nothing in this area has moved yet this week.

Latest in Gastric Cancer Management and Outcomes

Newest first · last 60 days

Response to: 'Rectal versus colonic submucosal cancer rates and procedural outcomes in large non-pedunculated polyps: French ESD registry data' by Van der Voort et al.
Gut · 7 Sept 2026 · Letter
Read the brief in JClub
- 2 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/41314787
Open in JClub
Risk of Stomach Cancer With Long-Term Use of Proton Pump Inhibitors.
Gastroenterology · 1 Sept 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/41759635
Open in JClub
Perioperative tislelizumab plus chemotherapy for locally advanced gastric cancer: A randomized, prospective phase 2 trial.
Cancer Cell · 10 Aug 2026 · Clinical Trial, Phase II
Perioperative tislelizumab plus chemotherapy significantly improves pathological response in tsMHC-II-positive gastric cancer patients, with a 61.8% mPR rate versus 26.5% for chemotherapy alone.
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42456653
Open in JClub
Ten-Year Follow-Up After Endoscopic Submucosal Dissection for Clinical T1a Undifferentiated-Type Early Gastric Cancer ≤2 cm Without Ulceration in a Nonrandomized, Single-Arm Confirmatory Trial (JCOG1009/1010).
Gastroenterology · 7 Aug 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42567329
Open in JClub
Adenoma detection and subsequent colorectal cancer risk: is the race really over?
Gut · 6 Aug 2026 · Journal Article
Read the brief in JClub
- 3 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/40579120
Open in JClub
Prospective evaluation of radical surgery for adenocarcinoma of oesophagogastric junction: real-world insights from the CLAEG study.
Gut · 6 Aug 2026 · Multicenter Study
Read the brief in JClub
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/41611521
Open in JClub

Follow this area in the app

Journals this month

All journals →

Moving areas, week to 3 Oct 2026

All research areas →

Read

Moved this week

Latest in Gastric Cancer Management and Outcomes

Response to: 'Rectal versus colonic submucosal cancer rates and procedural outcomes in large non-pedunculated polyps: French ESD registry data' by Van der Voort et al.

Risk of Stomach Cancer With Long-Term Use of Proton Pump Inhibitors.

Perioperative tislelizumab plus chemotherapy for locally advanced gastric cancer: A randomized, prospective phase 2 trial.

Ten-Year Follow-Up After Endoscopic Submucosal Dissection for Clinical T1a Undifferentiated-Type Early Gastric Cancer ≤2 cm Without Ulceration in a Nonrandomized, Single-Arm Confirmatory Trial (JCOG1009/1010).

Adenoma detection and subsequent colorectal cancer risk: is the race really over?

Prospective evaluation of radical surgery for adenocarcinoma of oesophagogastric junction: real-world insights from the CLAEG study.

Browse JClub